Profile
Alix Ventures is a venture capital firm based in San Francisco, California, founded in 2019. The firm focuses on the life sciences sector, particularly in TechBio, aiming to drive significant patient impact through innovative solutions. Alix Ventures partners with accomplished founders who have unique insights into solving critical problems in life sciences. The firm is known for its strong community of technical experts and industry insights, supporting startups that push the boundaries of what's possible.
Alix Ventures invests primarily in the healthcare, biotech, and life sciences sectors, with a focus on early-stage companies. They typically invest in Pre-Seed, Seed, and Series A rounds, with check sizes ranging from $100K to $500K. The firm primarily invests in the United States and has a portfolio that includes companies like iOrganBio, Strand Therapeutics, and Endpoint Health. Alix Ventures operates a BIOS community platform, providing resources and networking opportunities for its portfolio companies.
Notable investments by Alix Ventures include Endpoint Health - a drug discovery company, iOrganBio - a biotechnology firm, and Strand Therapeutics - a company focused on drug discovery. These investments highlight Alix Ventures' commitment to advancing human health through innovative life sciences solutions.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.